218 related articles for article (PubMed ID: 20423338)
1. Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity.
Puerta E; Hervias I; Goñi-Allo B; Zhang SF; Jordán J; Starkov AA; Aguirre N
Br J Pharmacol; 2010 May; 160(2):233-45. PubMed ID: 20423338
[TBL] [Abstract][Full Text] [Related]
2. Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice.
Barros-Miñones L; Goñi-Allo B; Suquia V; Beitia G; Aguirre N; Puerta E
Neuropharmacology; 2015 Jun; 93():124-33. PubMed ID: 25666033
[TBL] [Abstract][Full Text] [Related]
3. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders.
Peraile I; Granado N; Torres E; Gutiérrez-López MD; Moratalla R; Colado MI; O'Shea E
Psychopharmacology (Berl); 2013 Nov; 230(1):125-35. PubMed ID: 23681166
[TBL] [Abstract][Full Text] [Related]
4. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.
Peraile I; Torres E; Mayado A; Izco M; Lopez-Jimenez A; Lopez-Moreno JA; Colado MI; O'Shea E
Br J Pharmacol; 2010 Jan; 159(1):201-11. PubMed ID: 20015297
[TBL] [Abstract][Full Text] [Related]
6. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.
Ferreira PS; Nogueira TB; Costa VM; Branco PS; Ferreira LM; Fernandes E; Bastos ML; Meisel A; Carvalho F; Capela JP
Toxicol Lett; 2013 Feb; 216(2-3):159-70. PubMed ID: 23194825
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
Baumann MH; Wang X; Rothman RB
Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
[TBL] [Abstract][Full Text] [Related]
9. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
[TBL] [Abstract][Full Text] [Related]
10. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
Johnson BN; Yamamoto BK
J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
[TBL] [Abstract][Full Text] [Related]
11. Involvement of free radicals in MDMA-induced neurotoxicity in mice.
Cadet JL; Thiriet N; Jayanthi S
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS57-9. PubMed ID: 11435997
[TBL] [Abstract][Full Text] [Related]
12. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.
Camarero J; Sanchez V; O'Shea E; Green AR; Colado MI
J Neurochem; 2002 Jun; 81(5):961-72. PubMed ID: 12065608
[TBL] [Abstract][Full Text] [Related]
13. The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum.
Górska AM; Noworyta-Sokołowska K; Gołembiowska K
Pharmacol Rep; 2014 Aug; 66(4):718-21. PubMed ID: 24948078
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.
Halpin LE; Collins SA; Yamamoto BK
Life Sci; 2014 Feb; 97(1):37-44. PubMed ID: 23892199
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
16. Brain concentrations of d-MDMA are increased after stress.
Johnson EA; O'Callaghan JP; Miller DB
Psychopharmacology (Berl); 2004 May; 173(3-4):278-86. PubMed ID: 14735292
[TBL] [Abstract][Full Text] [Related]
17. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
Rodsiri R; Green AR; Marsden CA; Fone KC
J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
[TBL] [Abstract][Full Text] [Related]
18. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
[TBL] [Abstract][Full Text] [Related]
19. Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.
Jeng W; Wells PG
ACS Chem Neurosci; 2010 May; 1(5):366-80. PubMed ID: 22778832
[TBL] [Abstract][Full Text] [Related]
20. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.
Itzhak Y; Ali SF; Achat CN; Anderson KL
Psychopharmacology (Berl); 2003 Mar; 166(3):241-8. PubMed ID: 12590354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
